# FDA Inspection 1160917 - David Rayhan, M.D. - January 05, 2022

Source: https://www.keypedia.com/records/fda_inspections/david-rayhan-md/f0b12957-a9bd-4df7-b142-a9df1d3da26f
Source feed: FDA_Inspections

> FDA Inspection 1160917 for David Rayhan, M.D. on January 05, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1160917
- Company Name: David Rayhan, M.D.
- Inspection Date: 2022-01-05
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/david-rayhan-md/5cc1cc87-f045-4c06-bfef-f23e89cceb06

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c